Original Research

Page 9

Posts about this type

PCC
hs-CRP as a Biomarker and Endophenotype in Mania
JCP
Pharmacotherapy After CBT in Anxious Youth
JCP
Social Support and Suicidal Thoughts and Behaviors
JCP
Telehealth of CSC in Early Psychosis During COVID-19
PCC
Pharmacist-Led Dementia Care Rounds and Sleep Medication Use
PCC
High-Dose Therapy in Treatment-Refractory Psychosis
PCC
Therapeutic Dilemma of Wake-up Stroke
JCP
Bad Dreams and Nightmares Preceding Suicidal Behaviors
PCC
Impairment of Sexual Desire in Treatment-Resistant Depression
JCP
Measuring Executive Function in ADHD With the BRIEF-A
JCP
Effect of Benzodiazepines on Antidepressant Effects of Ketamine
PCC
Boredom, Loneliness, and Smartphone Addiction Among Young Adults
JCP
Suvorexant and Lemborexant for Prevention of Delirium
JCP
Relationship Between bvFTD and Psychiatric Disorders
PCC
History of Suicide Attempt and Clozapine in Veterans With Schizophrenia
JCP
Psychotropic Use in Youth With MDD and ADHD
PCC
Impact of ER Naltrexone on Readmission Rates in Alcohol Use Disorder
JCP
Overlapping Patterns of Suicide Attempts and Non-suicidal Self-Injuries in Adults
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ October 24, 2022

Among adults with self-injury behaviors, switching between episodes with and without suicidal intent is common and is associated with greater risk of suicidal behavior in the future.
PCC
Intracerebral Hemorrhage Outcomes and Related Clinical Conditions
JCP
Acceptability of Second-Line Antidepressant Medications
JCP
Economic Burden of Schizophrenia in the US
JCP
Frontothalamic Circuit Abnormalities in Patients With Bipolar Disorder and Suicide Attempts
PCC
Social Media Use Disorder and Emotional Intelligence
JCP
Sublingual Dexmedetomidine for Agitation in Schizophrenia